Drug Profile
Estradiol/norethisterone sequential transdermal - Elan Pharma
Latest Information Update: 15 May 2008
Price :
$50
*
At a glance
- Originator Amarin Corporation
- Class Estradiol congeners; Estrenes; Hormonal contraceptives; Hormonal replacements; Norpregnenes; Oral contraceptives; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Menopausal syndrome
Most Recent Events
- 01 Apr 2008 Discontinued - Phase-III for Menopausal syndrome in United Kingdom (Transdermal)
- 01 Apr 2008 Discontinued - Phase-III for Menopausal syndrome in USA (Transdermal)
- 23 Dec 2003 No development reported - Phase-III for Menopausal syndrome in United Kingdom (Transdermal)